HeartLab Inc. (CHL), a rapidly growing specialty clinical laboratory
and cardiovascular disease management company, today announced that its
fourth annual symposium, Where
Inflammation Meets Lipids®, will
focus on unique models and strategies for assessing, treating and
preventing chronic disease.
The symposium, one of the premier meetings of its kind, will be held at
the Irving Convention Center in Dallas on Oct. 17-18, 2013. Cleveland
HeartLab's annual educational symposium attracts hundreds of the best
primary care practitioners in the United States who are focused on
wellness and prevention. This year's program also is attracting leaders
from industry with similar goals, including improving patient outcomes
and reducing costs.
The company said 17 thought-leading experts will speak at this year's
program, engaging symposium participants on a range of topics related to
cardiovascular disease. This year's meeting also includes a special
reception at Cowboys Stadium, complete with interactive agility events.
In addition to panel discussions, attendees will be able to participate
in unique expert-led case study sessions designed to maximize attendee
participation. The symposium has been approved for 12 continuing medical
education credits by the American Academy of Family Physicians.
The symposium's featured speakers and the title of his or her talk
Kavita Patel, M.D., director of policy, White House Office of
Intergovernmental Affairs and Public Engagement, Thriving in Health
Michael Roizen, M.D., New York Times best-selling author of The
Real Age, and chairman, Cleveland Clinic Wellness Institute, Wellness
Works: Models and Strategies that Work
Connie Mariano, M.D., former director, White House Medical Unit and
physician to the president, Taking Care of the First Patient
Emad Rizk, M.D., president, McKesson Health Solutions, Navigating
the Complexity of New Value-Based Reimbursement Models
Other thought-leaders confirmed as speakers include Miles Snowden, M.D.,
chief medical officer, Optum; Mimi Guarneri, M.D., founder, Scripps
Center for Integrative Medicine; The Hon. Tommy Thompson, former
secretary, U.S. Department of Health and Human Services; and Marc Penn,
M.D., Ph.D., chief medical officer, Cleveland HeartLab Inc., and
director of research, Summa Cardiovascular Institute.
"We're excited for the fourth year of Cleveland HeartLab's annual
symposium, which demonstrates our continuing commitment to education and
the promotion of early risk identification and disease prevention," said
Jake Orville, president and chief executive of Cleveland HeartLab.
"Seventy-five cents of every health care dollar spent today goes to
treat chronic disease. This year's symposium will focus on strategies
for preventing chronic disease, keeping patients healthier and lowering
health care costs. Past participants have told us that our symposium
offers expertise and information they can't find anywhere else, which
translates directly into better patient care in their practices."
About Cleveland HeartLab
Cleveland HeartLab Inc. is an advanced clinical laboratory and
cardiovascular disease management company. Established in 2009, CHL
offers an array of proprietary testing and analysis focused on the
identification and reduction of cardiovascular inflammation. The company
operates a CLIA-certified and CAP-accredited national clinical
laboratory. CHL has developed prognostic tests, based on unique
molecular biomarkers, which are used by thousands of medical
practitioners for better prediction of risk beyond standard risk factors
such as cholesterol testing. CHL also has an innovative research and
development group that is tasked with the discovery and commercial
development of next-generation cardiovascular biomarkers for utilization
through the company's clinical laboratory. This valuable
research-enabled pipeline of tests and testing services is part of CHL's
novel intellectual property portfolio that targets large under-served
markets. For more information, visit us at www.clevelandheartlab.com.
Cleveland HeartLab Inc.
Jake Orville, 216-426-6081
The Luminis Group Ltd
Rod Hise, 608-770-7850